agilon health, inc. (AGL) Fair Value & Analysis
Healthcare · US · Market cap $1.9B
agilon health, inc.
AGL · US
Fair value as of: Jun 24, 2026
From 4 valuation models · updated 5 days ago
Share price +24.8% over the past month.
Price vs Fair Value (12 months)
12‑month range $7.68 – $115.71 · fair‑value band $25.64 – $42.73 · the $111.73 price screens above the $34.18 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
agilon health, inc. (AGL) currently trades at $111.73, while our model-based Fair Value estimate is $34.18 — implying the stock looks roughly 69.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, agilon health, inc. generated revenue of $5.8B at a net margin of -6.1%. Revenue declined 7.3% year over year. The balance sheet holds a net cash position of $137M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
agilon health, inc. reported revenue of $5.9B in FY2025 versus $1.5B in FY2021, a compound +40.5%/yr. Reported net income was −$405M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is agilon health, inc. (AGL) undervalued?
What is the fair value of AGL?
What is the quality score of AGL?
What is the revenue of agilon health, inc. (AGL)?
What is the net profit margin of AGL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.